The comatose patient

Matthias Girke

Last update: 17.09.2015

The outward unconsciousness of the comatose patient can be accompanied by inner consciousness. For this reason, a comatose patient should be treated as if she were awake and responsive, and her being were only “veiled.” There have been various reports documented of “awake” coma patients. Through what are called event-related brain potentials (ERPs), undetected waking states have been determined in patients in a “persistent vegetative state” or in a coma. The recorded ERPs of these patients were different, for example, when they were told, “Berlin is the capital of Germany”, than when they were told, “Paris is the capital of Germany.” We must act on the assumption of the presence of undetected waking states with the possibility of reflexivity in unconscious patients.

Further studies have shown that waking states can be determined in coma patients using functional magnetic resonance imaging (fMRI). One patient in a persistent vegetative state was asked to imagine that she was playing tennis. Her fMRI showed the same pattern that was documented in the brains of healthy test subjects who are imagining that they are playing tennis.
The contrast between outer unconsciousness and a lucid inner conscious experience with independent reflective capacity is especially impressive in the case of patients with near-death experiences. These observations call into question the relationship between consciousness and the nervous system, and give evidence of conscious experiences which take place independently of the physical body.

Research news

Mistletoe therapy in addition to standard immunotherapy in patients with non-small-cell lung cancer indicates improved survival rates 
Immunotherapy with PD-1/PD-L1 inhibitors has significantly improved the survival rates of patients with metastatic non-small-cell lung cancer (NSCLC). Results of a real-world data study (RWD) investigating the addition of Viscum album L. (VA) to chemotherapy have shown an association with improved survival in patients with NSCLC - regardless of age, degree of metastasis, performance status, lifestyle or oncological treatment. The mechanisms may include synergistic modulations of the immune response by PD-1/PD-L1 inhibitors and VA. However, the results should be taken with caution due to the observational and non-randomised study design. The study has been published open access in Cancers
https://doi.org/10.3390/cancers16081609.


Further information on Anthroposophic Medicine